- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Yedvobnick, B.
- Articles by Bhat, K. M.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Yedvobnick, B.
- Articles by Bhat, K. M.
Differential Effects of Drosophila Mastermind on Asymmetric Cell Fate Specification and Neuroblast Formation
Barry Yedvobnicka, Anumeha Kumara, Padmashree Chaudhurya, Jonathan Opraseuthb, Nathan Mortimerb, and Krishna Moorthi Bhatba Department of Biology, Emory University School of Medicine, Atlanta, Georgia 30322
b Department of Cell Biology, Emory University School of Medicine, Atlanta, Georgia 30322
Corresponding author: Krishna Moorthi Bhat, 413 Whitehead Biomedical Research Bldg., 415 Michael St., Emory University School of Medicine, Atlanta, GA 30322., kbhat{at}cellbio.emory.edu (E-mail)
Communicating editor: R. S. HAWLEY
| ABSTRACT |
|---|
During neurogenesis in the ventral nerve cord of the Drosophila embryo, Notch signaling participates in the pathway that mediates asymmetric fate specification to daughters of secondary neuronal precursor cells. In the NB4-2
GMC-1
RP2/sib lineage, a well-studied neuronal lineage in the ventral nerve cord, Notch signaling specifies sib fate to one of the daughter cells of GMC-1. Notch mediates this process via Mastermind (Mam). Loss of function for mam, similar to loss of function for Notch, results in GMC-1 symmetrically dividing to generate two RP2 neurons. Loss of function for mam also results in a severe neurogenic phenotype. In this study, we have undertaken a functional analysis of the Mam protein. We show that while ectopic expression of a truncated Mam protein induces a dominant-negative neurogenic phenotype, it has no effect on asymmetric fate specification. This truncated Mam protein rescues the loss of asymmetric specification phenotype in mam in an allele-specific manner. We also show an interallelic complementation of loss-of-asymmetry defect. Our results suggest that Mam proteins might associate during the asymmetric specification of cell fates and that the N-terminal region of the protein plays a role in this process.
THE central nervous system (CNS) of the Drosophila embryo provides an important paradigm for investigating the problem of asymmetric division of neural precursor cells during development. In the ventral nerve cord of the Drosophila embryo,
30 neuroblast (NB) cells in each hemi-segment delaminate in about five successive waves along the mediolateral and anterior-posterior axes in rows and columns in a stereotyped and spatio-temporal pattern (![]()
![]()
![]()
320 neurons and
30 glia, the other principal cell type in the CNS (![]()
![]()
Genetic and molecular evidence indicate that GMCs generally undergo an asymmetric cell division (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
RP2/sib lineage, loss of Notch or nb leads to the symmetric division of GMC-1. While both progeny assume RP2 fate in Notch mutants, they assume a sib fate in nb mutants (![]()
![]()
![]()
![]()
Mam is a glutamine-rich nuclear protein essential for Notch signaling (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
| MATERIALS AND METHODS |
|---|
Fly stocks and genetics:
The following mam alleles were used in this study: ethyl methanesulfonate (EMS)-induced allele cn mamlL42bw sp/CyO, a spontaneous inversion mamN2G/CyO, and the hybrid dysgenic allele mamHD 10/6/CyO (![]()
![]()
Heat shock-GAL4/UAS-Mam truncation strains:
Construction of Mam truncations in pUAST is described in ![]()
![]()
![]()
Heat-shock regimen during embryogenesis:
Embryos were collected for 2 hr and then either heat-shocked immediately at 41° for 30 min or aged at various intervals and then heat-shocked (see text for details). Embryos were then aged again for different durations prior to fixation and then stained with anti-Eve or anti-Eve and anti-Zfh-1.
Rescue experiments:
UAS-MamN and Hs-GAL4 transgenes were introduced into either the mamHD10/6 or the mamIL42 background. Embryos from these combinations were collected for 2 hr, aged 6 hr (68 hr old) and the UAS-MamN was induced by heat shock at 41° for 30 min. These embryos were allowed to grow at room temperature until they reached
14 hr or older before fixing and staining with anti-Eve.
Sequencing of the mam mutant alleles:
mamIL42 homozygous embryos were identified by the presence of CNS defects (visualized with Eve staining) and lack of balancer-specific staining. DNA from several individual homozygous embryos were individually prepared and the mam coding region between MamH and MamN (see Fig 2A) was amplified from these individual DNA preparations. The amplified DNA was then sequenced in both directions.
|
|
Antibodies and immunostaining:
Embryos were stained using standard immunohistochemistry procedures. Embryos were fixed and stained with Eve (1:2000), Eve and Zfh-1 (1:400), or LacZ (1:2000). For light microscopy, alkaline phosphatase or 3,3'-diaminobenzidine-conjugated secondary antibodies were used. For confocal, FITC and Cy5 secondary antibodies were used. Embryos of appropriate genotypes (i.e., mutants or rescue embryos) were identified using blue balancers and or marker phenotypes.
| RESULTS |
|---|
The GMC-1
RP2/sib lineage:
The GMC-1
RP2/sib lineage, generated by NB4-2, is one of the well-studied neuronal lineages in the ventral nerve cord of the Drosophila embryo (reviewed in ![]()
4.5 hr old) of embryogenesis (![]()
![]()
1.5 hr after formation. The GMC-1 divides
1.5 hr later to generate two cells, the RP2 and the sib.
There are several well-established ways to distinguish a GMC-1, an RP2, and a sib (see ![]()
![]()
![]()
Loss of function for mam causes both loss-of-asymmetry and neurogenic phenotypes:
Most mam alleles show a neurogenic phenotype (![]()
![]()
![]()
![]()
Expression of the MamH truncation interferes with both the neurogenic and the asymmetry functions of wild-type Mam:
Mam protein has several distinct domains, such as an N-terminal basic domain, a centrally located acidic domain, and a C-terminal acidic domain (Fig 2A). First, using a transgenic line carrying an N-terminal truncation of Mam (MamH; see Fig 2A) under the control of upstream activator sequence (UAS; ![]()
![]()
![]()
10% of the hemisegments). Nonetheless, these results indicate that this truncated form of Mam functions as a dominant negative competing with the wild-type Mam and produces both neurogenic and loss-of-asymmetry phenotypes. We also examined an allele of mam, N2G, in which an inversion breaks the gene in such a way that it is expected to produce a truncated form of the protein that is 12 amino acids shorter than MamH (Fig 2A). In this allele, we observed both the neurogenic and the loss-of-asymmetry phenotypes (Fig 2F).
Expression of the MamN truncation interferes with the neurogenic function of wild-type Mam but not with its asymmetry function:
We next examined a transgenic line carrying a longer form of the Mam protein, MamN (see Fig 2A; ![]()
![]()
Loss of Mam or Notch activity in imaginal discs has been shown to cause adult phenotypes (see ![]()
![]()
|
MamN rescues the loss-of-asymmetry phenotype in a hypomorphic mam allele:
The above results indicate that MamN can interfere with wild-type Mam function during neuroblast formation and thus induce a neurogenic phenotype, whereas it cannot interfere with the wild-type protein during asymmetric fate specification. We hypothesized that perhaps MamN has the part of the protein required for specifying sib identity and thus it does not function as a dominant negative during asymmetric fate specification. To test this hypothesis, we sought to rescue the loss-of-asymmetry phenotype in two different alleles, mamHD10/6 and mamIL42. mamHD10/6 is a P-element insertion allele in which the P element is inserted in the untranslated first exon (![]()
![]()
![]()
|
|
|
mamIL42 and mamHD10/6 show interallelic complementation:
As discussed above, ectopic expression of MamN elicits a neurogenic defect but not the loss-of-asymmetry phenotype. Further, MamN can rescue the loss of asymmetric division in mamHD10/6 but not in mamIL42. These results led us to think that MamN can rescue the asymmetric division defect only in the presence of some wild-type Mam protein. This raised the possibility that MamN might interact with wild-type Mam protein during the specification of sib fate. We tested this idea genetically by looking for interallelic complementation. When two molecules of the same protein interact with one another, this is often revealed by interallelic complementation (cf. ![]()
mamIL42 carries a suppressor of the neurogenic defect but not the asymmetry defect:
The strong neurogenic effect of MamN but the absence of a similar strong neurogenic defect in mamIL42 (which is predicted to produce a truncated MamN-like protein; see Fig 5A) was unexpected. For example, the absence of a strong neurogenic defect in mamIL42 indicates that the truncated protein has all the necessary function for normal NB formation. However, the dominant-negative neurogenic effect of MamN shows that this truncated protein does not carry the function necessary for normal NB formation. While MamN carries an additional seven amino acids compared to MamIL42, we considered the possibility that the mamIL42 mutant carries a suppressor(s) of the neurogenic defect but not a suppressor(s) of loss-of-asymmetry defect. Since a straightforward outcrossing of mamIL42 does not result in the loss of suppressor(s), the suppressor(s) are likely to be located on the same chromosome as mamIL42. Therefore, we subjected mamIL42 to one round of recombination and examined embryo collections from recombinants. Consistent with the possibility of the presence of a partial suppressor of neurogenic defect, we recovered mamIL42 chromosomes that showed a strong neurogenic defect (Fig 5C). These embryos, however, showed the loss-of-asymmetry defect to the same extent as the embryos from the original mamIL42 strain (Fig 5C; see Table 1). We have not yet mapped the suppressor(s) nor have we determined that the effect is due to a single locus.
mam phenotype is epistatic to the numb phenotype:
Recent studies indicate that inscuteable (insc) and nb play a crucial role in the terminal asymmetric division of GMC-1 of the RP2/sib lineage (![]()
![]()
![]()
![]()
![]()
![]()
|
| DISCUSSION |
|---|
The canonical Notch pathway described for Drosophila (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
In the ventral nerve cord of the Drosophila embryo, the Notch pathway mediates terminal asymmetric division of secondary neuronal precursor cells (![]()
![]()
![]()
![]()
RP2/sib lineage during GMC-1 division, the Inscuteable protein asymmetrically localizes to the apical end, which forces Numb to localize to the basal end. Basally localized Numb then segregates to the future RP2. The function of Numb is to prevent the cleaving of the intracellular domain of Notch. In the absence of Numb, the intracellular domain of Notch gets cleaved and then translocated into the nucleus where it specifies a sib fate by complexing with Su(H) and Mam and activating downstream target genes. Previous results also show that for the specification of an RP2 identity Numb is not required, but it is required to prevent that cell from becoming a sib in the presence of an intact Notch pathway.
In this article, we show differential effects of Mam on asymmetric cell fate specification vs. neuroblast formation in the ventral nerve cord of the Drosophila embryo. We show that a Mam truncation, which has the basic and the first acidic domain (MamN), rescues the asymmetric cell fate specification defect in an allele-specific manner. These conclusions are based on several lines of evidence. First, a transgene that encodes this truncated Mam protein causes a dominant-negative neurogenic defect, but it does not cause a dominant-negative effect on asymmetric division. Thus, expression of this transgene during the asymmetric division of GMC-1 does not cause a duplication of RP2 as one would expect if this transgene functions as a dominant negative. The same transgene when expressed earlier when NBs are formed causes a neurogenic defect. This indicates that the truncated transgene functions as a dominant negative but only during the earlier neurogenic process. Second, MamN rescues the asymmetry defect in one of the mam mutant alleles, mamHD10/6. This is a hypomorphic P-element insertion allele (![]()
![]()
![]()
Our sequence analysis of mamIL42 suggests that this allele encodes a Mam protein that is similar to MamN (although it is seven amino acids shorter). The inability of MamN to rescue mamIL42 argues that this truncated protein in combination with MamN is not sufficient to rescue the asymmetry defect. However, the interallelic complementation between mamHD10/6 and mamIL42 (a situation very similar to the mamHD10/6;MamN combination) also suggests that MamIL42 and MamHD10/6 proteins (which are expected to be wild type, but present at reduced levels) interact to rescue the loss of asymmetric division of GMC-1. These results raise the question as to whether or not MamN (which is similar to the Mam protein in the mamIL42 allele) has all the necessary function for generating asymmetry. Since it does not rescue the asymmetry defect in mamIL42, clearly it does not have all the necessary information. However, it does have the required function in the presence of some presumably wild-type protein (i.e., in mamHD10/6 background). This is consistent with the fact that MamN does not function as a dominant negative during the asymmetric division of GMC-1 but only at earlier stages during the formation of NBs.
There might be some difference between MamN and MamIL42 in their ability to complement loss of asymmetric division in mamHD10/6. This is indicated by the findings that while MamN can rescue the asymmetry defect in mamHD10/6, the interallelic complementation of the asymmetry phenotype between mamIL42 and mamHD10/6 is not as complete as rescue of mamHD10/6 by MamN (see Table 1). This may, in part, be due to the seven-amino-acid difference between MamN and MamIL42. Alternatively, there may be a protein-level difference between the two cases; in the former, MamN is expressed at high levels under Hs-GAL4, whereas in the latter mamIL42 is under the control of the mam promoter. Yet, the seven-amino-acid residues could make some difference, given that these amino acids are mostly glutamine residues, which can be involved in multimerization of proteins (![]()
Our results show that mamIL42 carries a partial suppressor of neurogenic defect since a strong neurogenic defect can be restored to this allele upon recombination. This is consistent with the result that expression of MamN elicits a strong dominant-negative neurogenic defect. However, this suppressor in mamIL42 has no modifying effect on the loss-of-asymmetry phenotype of mamIL42, as indicated by the fact that there was no change in the penetrance of this defect between the original and the recombinant mamIL42. We have not mapped the location of this suppressor(s) beyond its tentative assignment to chromosome 2.
Previous studies utilizing MamH and MamN have demonstrated that both truncations elicited dominant-negative effects when overexpressed in imaginal tissues (![]()
![]()
![]()
![]()
![]()
![]()
![]()
Finally, our results indicate that the mam phenotype in the RP2/sib lineage (symmetrical division of GMC-1 into RP2 and sib) is epistatic to the numb phenotype (symmetrical division of GMC-1 into two sibs). During the division of GMC-1, Insc localizes to the apical end of GMC-1, which in turn segregates Nb to the basal end. The cell that inherits Nb is specified as RP2 due to the ability of Nb to block Notch signaling, whereas the cell that does not inherit Nb (but inherits Insc) is specified as sib by Notch. Thus, in insc mutants, both daughters of the GMC-1 adopt an RP2 fate whereas in nb mutants they assume a sib fate (![]()
![]()
![]()
| ACKNOWLEDGMENTS |
|---|
We thank Manfred Frasch and Zhi-Chun Lai for the generous supply of antibodies and Spyros Artavanis-Tsakonas, Haig Keshishian, and the Bloomington Stock Center for various stocks. Comments from members of the Bhat lab and Yedvobnick lab were appreciated. B.Y. wishes to thank K.B. and the members of the Bhat lab for generously sharing their time and expertise during his time in their lab. This work is supported by a grant from the National Science Foundation to B.Y. (IBN 9904411) and a grant from the National Institutes of Health to K.B. (GM58237).
Manuscript received July 7, 2003; Accepted for publication November 24, 2003.
| LITERATURE CITED |
|---|
ARTAVANIS-TSAKONAS, S., M. D. RAND, and R. J. LAKE, 1999 Notch signaling: cell fate control and signal integration in development. Science 284:770-776.
BAROLO, S., T. STONE, A. G. BANG, and J. W. POSAKONY, 2002 Default repression and Notch signaling: Hairless acts as an adaptor to recruit the corepressors Groucho and dCtBP to Suppressor of Hairless. Genes Dev. 16:1964-1976.
BETTLER, D., S. PEARSON, and B. YEDVOBNICK, 1996 The nuclear protein encoded by the Drosophila neurogenic gene mastermind is widely expressed and associates with specific chromosomal regions. Genetics 143:859-875.[Abstract]
BHAT, K. M., 1999 Segment polarity genes in neuroblast formation and identity specification during Drosophila neurogenesis. Bio-Essays 21:472-485.[CrossRef][Medline]
BHAT, K. M. and P. SCHEDL, 1994 The Drosophila miti-mere gene, a member of the POU family, is required for the specification of the RP2/sibling lineage during neurogenesis. Development 120:1501-1519.
BHAT, K. M., S. J. POOLE, and P. SCHEDL, 1995 The miti-mere and pdm1 genes collaborate during specification of the RP2/sib lineage in Drosophila neurogenesis. Mol. Cell. Biol. 15:4052-4063.[Abstract]
BOSSING, T., G. UDOLPH, C. Q. DOE, and G. M. TECHNAU, 1996 The embryonic central nervous system lineages of Drosophila melanogaster. I. Neuroblast lineages derived from the ventral half of the neuroectoderm. Dev. Biol. 179:41-64.[CrossRef][Medline]
BUESCHER, M., S. L. YEO, G. UDOLPH, M. ZAVORTINK, and X. YANG et al., 1998 Binary sibling neuronal cell fate decisions in the Drosophila embryonic central nervous system are nonstochastic and require inscuteable-mediated asymmetry of ganglion mother cells. Genes Dev. 12:1858-1870.
DOE, C. Q., 1992 Molecular markers for identified neuroblasts and ganglion mother cells in the Drosophila central nervous system. Development 116:855-863.[Abstract]
DYE, C. A., J. K. LEE, R. C. ATKINSON, R. BREWSTER, and P. L. HAN et al., 1998 The Drosophila sanpodo gene controls sibling cell fate and encodes a tropomodulin homolog, an actin/tropomyosin-associated protein. Development 125:1845-1856.[Abstract]
FEHON, R. G., P. J. KOOH, I. REBAY, C. C. REGAN, and T. XU et al., 1990 Molecular interactions between the protein products of the neurogenic loci Notch and Delta, two EGF-homologous genes in Drosophila.. Cell 61:523-534.[CrossRef][Medline]
FRYER, C. J., E. LAMAR, I. TURBACHOVA, C. KINTNER, and K. A. JONES, 2002 Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. Genes Dev. 16:1397-1411.
HARTENSTEIN, V. and J. A. CAMPOS-ORTEGA, 1984 Early neurogenesis in wild-type Drosophila melanogaster. Roux's Arch. Dev. Biol. 193:308-325.[CrossRef]
HARTENSTEIN, V. and J. W. POSAKONY, 1990 A dual function of the Notch gene in Drosophila sensillum development. Dev. Biol. 142:13-30.[CrossRef][Medline]
HEITZLER, P. and P. SIMPSON, 1993 Altered epidermal growth factor-like sequences provide evidence for a role of Notch as a receptor in cell fate decisions. Development 117:1113-1123.[Abstract]
HELMS, W., H. LEE, M. AMMERMAN, A. L. PARKS, and M. A. MUSKAVITCH et al., 1999 Engineered truncations in the Drosophila mastermind protein disrupt Notch pathway function. Dev. Biol. 215:358-374.[CrossRef][Medline]
HENKEL, T., P. D. LING, S. D. HAYWARD, and M. G. PETERSON, 1994 Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal binding protein Jk. Science 265:92-95.
HIRATA, J., H. NAKAGOSHI, Y. NABESHIMA, and F. MATSUZAKI, 1995 Asymmetric segregation of the homeodomain protein prospero during Drosophila development. Nature 377:627-630.[CrossRef][Medline]
KITAGAWA, M., T. OYAMA, T. KAWASHIMA, B. YEDVOBNICK, and A. KUMAR et al., 2001 A human protein with sequence similarity to Drosophila mastermind coordinates the nuclear form of notch and a CSL protein to build a transcriptional activator complex on target promoters. Mol. Cell. Biol. 21:4337-4346.
KNOBLICH, J. A., L. Y. JAN, and Y. N. JAN, 1995 Asymmetric segregation of numb and prospero during cell division. Nature 377:624-627.[CrossRef][Medline]
LEAR, B. C., J. B. SKEATH, and N. H. PATEL, 1999 Neural cell fate in rca1 and cycA mutants: the roles of intrinsic and extrinsic factors in asymmetric division in the Drosophila central nervous system. Mech. Dev. 88:207-219.[CrossRef][Medline]
MEHTA, B. and K. M. BHAT, 2001 Slit signaling promotes the terminal asymmetric division of neural precursor cells in the Drosophila CNS. Development 128:3161-3168.
MUMM, J. S. and R. KOPAN, 2000 Notch signaling: from the outside in. Dev. Biol. 228:151-165.[CrossRef][Medline]
PARKS, A. L., K. M. KLUEG, J. R. STOUT, and M. A. MUSKAVITCH, 2000 Ligand endocytosis drives receptor dissociation and activation in the Notch pathway. Development 127:1373-1385.[Abstract]
PASCAL, E. and R. TJIAN, 1991 Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev. 5:1646-1656.
PETCHERSKI, A. G. and J. KIMBLE, 2000a Mastermind is a putative activator for Notch. Curr. Biol. 10:R471-R473.[CrossRef][Medline]
PETCHERSKI, A. G. and J. KIMBLE, 2000b LAG-3 is a putative transcriptional activator in the C. elegans Notch pathway. Nature 405:364-368.[CrossRef][Medline]
RAMAIN, P., K. KHECHUMIAN, L. SEUGNET, N. ARBOGAST, and C. ACKERMANN et al., 2001 Novel Notch alleles reveal a Deltex-dependent pathway repressing neural fate. Curr. Biol. 13:1729-1738.
SCHMID, A. T., T. L. TINLEY, and B. YEDVOBNICK, 1996 Transcription of the neurogenic gene mastermind during Drosophila development. J. Exp. Zool. 274:207-220.[CrossRef][Medline]
SCHMIDT, H., C. RICKERT, T. BOSSING, O. VEF, and J. URBAN et al., 1997 The embryonic central nervous system lineages of Drosophila melanogaster. II. Neuroblast lineages derived from the dorsal part of the neuroectoderm. Dev. Biol. 189:186-204.[CrossRef][Medline]
SCHULDT, A. J. and A. H. BRAND, 1999 Mastermind acts downstream of notch to specify neuronal cell fates in the Drosophila central nervous system. Dev. Biol. 205:287-295.[CrossRef][Medline]
SKEATH, J. B. and C. Q. DOE, 1998 Sanpodo and Notch act in opposition to Numb to distinguish sibling neuron fates in the Drosophila CNS. Development 125:1857-1865.[Abstract]
SMOLLER, D. A., C. FRIEDEL, A. SCHMID, D. BETTLER, and L. LAM et al., 1990 The Drosophila neurogenic locus mastermind encodes a nuclear protein unusually rich in amino acid homopolymers. Genes Dev. 4:1688-1700.
SPANA, E. and C. Q. DOE, 1995 The prospero transcription factor is asymmetrically localized to the cell cortex during neuroblast mitosis in Drosophila. Development 121:3187-3195.[Abstract]
SPANA, E. and C. Q. DOE, 1996 Numb antagonizes Notch signaling to specify sibling neuron cell fates. Neuron 17:21-26.[CrossRef][Medline]
TANG, T. T., S. E. BICKEL, L. M. YOUNG, and T. L. ORR-WEAVER, 1998 Maintenance of sister-chromatid cohesion at the centromere by the Drosophila MEI-S332 protein. Genes Dev. 12:3843-3856.
WAI, P., B. TRUONG, and K. M. BHAT, 1999 Cell division genes promote asymmetric interaction between numb and Notch in the Drosophila CNS. Development 126:2759-2770.[Abstract]
WU, L., J. C. ASTER, S. C. BLACKLOW, R. LAKE, and S. ARTAVANIS-TSAKONAS et al., 2000 MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nat. Genet. 26:484-489.[CrossRef][Medline]
YE, Y., N. KUKINOVA, and M. FORTINI, 1999 Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants. Nature 398:525-529.[CrossRef][Medline]
YEDVOBNICK, B., D. A. SMOLLER, P. YOUNG, and D. MILLS, 1988 Molecular analysis of the neurogenic locus mastermind of Drosophila melanogaster. Genetics 118:482-497.
This article has been cited by other articles:
![]() |
I. Gaziova and K. M. Bhat Ancestry-independent fate specification and plasticity in the developmental timing of a typical Drosophila neuronal lineage Development, January 15, 2009; 136(2): 263 - 274. [Abstract] [Full Text] [PDF] |
||||
- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Yedvobnick, B.
- Articles by Bhat, K. M.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Yedvobnick, B.
- Articles by Bhat, K. M.






